No Data
Bionano Announces Publication Showing That OGM Identifies Variant That Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia
Bionano Genomics Closes $10 Million Offering of Shares, Warrants
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.
Investors Still Aren't Entirely Convinced By Bionano Genomics, Inc.'s (NASDAQ:BNGO) Revenues Despite 33% Price Jump
12 Health Care Stocks Moving In Friday's Pre-Market Session
Sector Update: Health Care Stocks Rise in Late Afternoon Trading